Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

    Recruiting

    2 1 1 1
    Germany
  • Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Austria Belgium Denmark Estonia Finland France +8
  • Study of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia Germany Italy Lithuania Portugal Romania +1
  • Study on Stopping Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia Who Are Responding to Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Ziftomenib with Chemotherapy for Children with Relapsed or Refractory Acute Leukemia

    Recruiting

    1 1 1 1
    Austria France Italy The Netherlands Spain
  • Study on Teicoplanin for Preventing Infections in Children with Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark The Netherlands Spain
  • Study on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Romania Spain
  • Study of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study of azacitidine combined with low-dose venetoclax treatment for patients with acute myeloid leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Denmark Finland Norway Sweden